Cargando…
Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial
SIMPLE SUMMARY: Gastroesophageal adenocarcinoma (GOA) is a cancer that has poor survival. Most cases are diagnosed when a cure is not possible, and treatment often has many side effects. It occurs less often and is associated with better outcomes in females. The reason for this is not known. We soug...
Autores principales: | Baxter, Mark A., Spender, Lindsay C., Walsh, Shaun, Bray, Susan, Skinner, Gemma, King, Sharon, Hall, Peter S., Seymour, Matthew J., Petty, Russell D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177024/ https://www.ncbi.nlm.nih.gov/pubmed/37174057 http://dx.doi.org/10.3390/cancers15092591 |
Ejemplares similares
-
Real-world challenge for clinicians treating advanced gastroesophageal adenocarcinoma (Review)
por: Baxter, Mark A., et al.
Publicado: (2021) -
Combining precision medicine and prophylaxis in oesophageal squamous cell carcinoma
por: Baxter, Mark A., et al.
Publicado: (2020) -
Frailty and treatment outcome in advanced gastro-oesophageal cancer: An exploratory analysis of the GO2 trial
por: Pearce, Jessica, et al.
Publicado: (2022) -
Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed
por: Meemanage, Madusha, et al.
Publicado: (2020) -
Classical oestrogen receptor is not detectable in pancreatic adenocarcinoma.
por: Taylor, O. M., et al.
Publicado: (1992)